A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDEÒ Drug Eluting Bioresorbable Scaffold

The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD, which according to the American Heart Association affects more than 200 million people globally, and 10 to 12 million in the U.S. older than the age of 40.  The most common type of PAD affects the lower-extremity where blood flow is reduced to the legs and feet.  Each year, approximately 150,000 leg amputations are performed in the U.S. alone.      

Clinical Trials

osteolabs Publishes First Real-World Evidence Data from Close to 3, 000 OsteoTest Patient Samples

“We are very excited about the results from this collaborative effort that have now culminated in a publication in Bone, “ said Prof. Anton Eisenhauer who is a key inventor of the CIM technology and osteolabs´ Chief Scientific Officer. “This larger subset of routine clinical samples fully supports the potential for OsteoTest to qualify as a new universal diagnostic method for early osteoporosis risk assessment and therapeutic control.”

Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer

Genprex notes the patients in the Company’s lung cancer clinical trials are being treated with the Company’s lead drug candidate, Reqorsa® (quaratusugene ozeplasmid) Gene Therapy. Two patients in the Acclaim-1 study have had prolonged Progression Free Survival (PFS) and importantly, the first treated patient in the Acclaim-3 study attained a Partial Remission (PR) from the start of maintenance therapy.

Biotechnology News

TMRW Life Sciences and Cryoport Systems Form Strategic Partnership

“This partnership with Cryoport reflects our dedication to providing patients and clinics with the highest standard of care,” said Louis Villalba, TMRW’s CEO. “Cryoport’s reputation for excellence in reproductive biologistics, paired with TMRW’s cutting-edge specimen management technology and safety certifications, delivers unmatched security and peace of mind for transporting specimens in the fertility space.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

CAR T Cell Therapy

CAR T Cell Therapy Is Offering Life-lines to Cancer Patients, but Only to Those Who Can Afford It | By Dr. Brandon McNaughton, Chief Executive Officer and Co-Founder of Akadeum

The creation of CAR T cell therapy begins with collection of the patient’s blood and separation of the lymphocytes. These include T cells, B cells, and innate lymphoid cells, all of which are separated through apheresis (leukapheresis). It is this separation process which, if optimized, has the potential to revolutionize immunotherapy treatments for cancer patients.

Eliane Schutte, Xeltis CEO

New Living Blood Vessels Created Through Restorative Devices Open Unthinkable Treatment Avenues | By Eliane Schutte, Xeltis CEO

The latest results from a clinical trial presented today at the VEITHsymposium in New York City demonstrate how new living blood vessels created through restorative medical devices have become reality and can open unthinkable treatment avenues for patients. Xeltis is developing cardiovascular devices, namely artificial vessels and valves, that gradually create living and long-lasting vessels made of patients’ own, new healthy tissue.

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Obsidian Therapeutics Announces Oversubscribed $160.5 Million Series C Financing to Drive OBX-115 Clinical Development

Proceeds from the financing will advance Obsidian’s lead engineered tumor-infiltrating lymphocyte (TIL) program, OBX-115, in its ongoing trials for patients with melanoma and non-small cell lung cancer (NSCLC). Obsidian Therapeutics is focused on enrolling patients and reaching key clinical and regulatory milestones, as well as manufacturing scale-up ahead of pivotal trial readiness.

$6.7M In Federal Grants Awarded to Develop Tech to Monitor, Treat Chronic Eye Diseases

Research teams led by a faculty member in Purdue University’s College of Engineering will use two grants from the National Eye Institute totaling $6.7 million to further develop specialized smart soft contact lenses that continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes.

Market Reports

Advancements In Imaging

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Medical Diagnostics

The Future of Medical Diagnostics

This article delves into some of the most exciting advancements and innovations in the field, demonstrating the incredible potential for medical diagnostics in the years to come.

Healthcare Careers

Nurses Corner

Future of Nursing

The Future of Nursing and How It Will Be Impacted by Technology

Nursing is evolving, but its future is secure for those who have the right professional training. Rather than worrying about whether or not their jobs will disappear as technology improves, nurses should make time to gain additional credentials, including information technology so that they can evolve with the profession.

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.